Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib.

de Velasco G, Ruiz-Granados Á, Reig O, Massari F, Climent Duran MA, Verzoni E, Graham J, Llarena R, De Tursi M, Donskov F, Iglesias C, Pandha HS, Garcia Del Muro X, Procopio G, Oudard S, Castellano D, Albiges L

Open source

DOI: 10.1111/bju.15356
Published: 2021 Aug
Container: BJU international
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/bju.15356,
  title = {Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib.},
  author = {de Velasco G and Ruiz-Granados Á and Reig O and Massari F and Climent Duran MA and Verzoni E and Graham J and Llarena R and De Tursi M and Donskov F and Iglesias C and Pandha HS and Garcia Del Muro X and Procopio G and Oudard S and Castellano D and Albiges L},
  year = {2021},
  journal = {BJU international},
  doi = {10.1111/bju.15356},
  url = {https://doi.org/10.1111/bju.15356}
}

RIS

TY  - JOUR
TI  - Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib.
AU  - de Velasco G
AU  - Ruiz-Granados Á
AU  - Reig O
AU  - Massari F
AU  - Climent Duran MA
AU  - Verzoni E
AU  - Graham J
AU  - Llarena R
AU  - De Tursi M
AU  - Donskov F
AU  - Iglesias C
AU  - Pandha HS
AU  - Garcia Del Muro X
AU  - Procopio G
AU  - Oudard S
AU  - Castellano D
AU  - Albiges L
PY  - 2021
JO  - BJU international
DO  - 10.1111/bju.15356
UR  - https://doi.org/10.1111/bju.15356
ER  -

APA

G, D. V., Á, R., O, R., F, M., MA, C. D., E, V., J, G., R, L., M, D. T., F, D., C, I., HS, P., X, G. D. M., G, P., S, O., D, C., & L, A. (2021). Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib.. BJU international. https://doi.org/10.1111/bju.15356

Source records

pubmed · retrieved 2026-09-26T02:08:23.062Z